title: Bipolar II disorder : epidemiology, diagnosis and management.
abstract: Bipolar II disorder (BP-II) is defined, by DSM-IV, as recurrent episodes of depression and hypomania. Hypomania, according to DSM-IV, requires elevated (euphoric) and/or irritable mood, plus at least three of the following symptoms (four if mood is only irritable): grandiosity, decreased need for sleep, increased talking, racing thoughts, distractibility, overactivity (an increase in goal-directed activity), psychomotor agitation and excessive involvement in risky activities. This observable change in functioning should not be severe enough to cause marked impairment of social or occupational functioning, or to require hospitalisation. The distinction between BP-II and bipolar I disorder (BP-I) is not clearcut. The symptoms of mania (defining BP-I) and hypomania (defining BP-II) are the same, apart from the presence of psychosis in mania, and the distinction is based on the presence of marked impairment associated with mania, i.e. mania is more severe and may require hospitalisation. This is an unclear boundary that can lead to misclassification; however, the fact that hypomania often increases functioning makes the distinction between mania and hypomania clearer. BP-II depression can be syndromal and subsyndromal, and it is the prominent feature of BP-II. It is often a mixed depression, i.e. it has concurrent, usually subsyndromal, hypomanic symptoms. It is the depression that usually leads the patient to seek treatment.DSM-IV bipolar disorders (BP-I, BP-II, cyclothymic disorder and bipolar disorder not otherwise classified, which includes very rapid cycling and recurrent hypomania) are now considered to be part of the 'bipolar spectrum'. This is not included in DSM-IV, but is thought to also include antidepressant/substance-associated hypomania, cyclothymic temperament (a trait of highly unstable mood, thinking and behaviour), unipolar mixed depression and highly recurrent unipolar depression.BP-II is underdiagnosed in clinical practice, and its pharmacological treatment is understudied. Underdiagnosis is demonstrated by recent epidemiological studies. While, in DSM-IV, BP-II is reported to have a lifetime community prevalence of 0.5%, epidemiological studies have instead found that it has a lifetime community prevalence (including the bipolar spectrum) of around 5%. In depressed outpatients, one in two may have BP-II. The recent increased diagnosing of BP-II in research settings is related to several factors, including the introduction of the use of semi-structured interviews by trained research clinicians, a relaxation of diagnostic criteria such that the minimum duration of hypomania is now less than the 4 days stipulated by DSM-IV, and a probing for a history of hypomania focused more on overactivity (increased goal-directed activity) than on mood change (although this is still required for a diagnosis of hypomania). Guidelines on the treatment of BP-II are mainly consensus based and tend to follow those for the treatment of BP-I, because there have been few controlled studies of the treatment of BP-II. The current, limited evidence supports the following lines of treatment for BP-II. Hypomania is likely to respond to the same agents useful for mania, i.e. mood-stabilising agents such as lithium and valproate, and the second-generation antipsychotics (i.e. olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole). Hypomania should be treated even if associated with overfunctioning, because a depression often soon follows hypomania (the hypomania-depression cycle). For the treatment of acute BP-II depression, two controlled studies of quetiapine have not found clearcut positive effects. Naturalistic studies, although open to several biases, have found antidepressants in acute BP-II depression to be as effective as in unipolar depression; however, one recent large controlled study (mainly in patients with BP-I) has found antidepressants to be no more effective than placebo. Results from naturalistic studies and clinical observations on mixed depression, while in need of replication in controlled studies, indicate that antidepressants may worsen the concurrent intradepression hypomanic symptoms. The only preventive treatment for both depression and hypomania that is supported by several, albeit older, controlled studies is lithium. Lamotrigine has shown some efficacy in delaying depression recurrences, but there have also been several negative unpublished studies of the drug in this indication.
authors: Hecker Psychiatry Research Center, a University of California at San Diego (USA) Collaborating Center at Forli, Italy. FrancoBenazzi@FBenazzi.it
authors: Franco
authors: F
authors: Benazzi
mesh_terms: D000328:Adult; D001714:Bipolar Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000523:psychology; D003937:Diagnosis, Differential; D006801:Humans; D011569:Psychiatric Status Rating Scales
references: Arch Gen Psychiatry. 1997 Apr;54(4):329-36
references: 9107149
references: Arch Gen Psychiatry. 1982 Sep;39(9):1065-9
references: 6810839
references: Arch Gen Psychiatry. 1982 Nov;39(11):1344-5
references: 6814397
references: J Affect Disord. 2006 Apr;91(2-3):133-8
references: 16458364
references: Am J Psychiatry. 1983 Sep;140(9):1127-33
references: 6351641
references: J Affect Disord. 2005 Feb;84(2-3):187-96
references: 15708416
references: Arch Gen Psychiatry. 2005 Jun;62(6):593-602
references: 15939837
references: J Clin Psychopharmacol. 1998 Oct;18(5):414-7
references: 9790160
references: Biol Psychiatry. 2004 Jul 1;56(1):54-60
references: 15219473
references: J Affect Disord. 2003 Jan;73(1-2):65-74
references: 12507739
references: J Affect Disord. 2006 Jun;92(2-3):205-14
references: 16516304
references: Bipolar Disord. 2004 Oct;6(5):440-1
references: 15383139
references: Arch Gen Psychiatry. 1976 Jan;33(1):117-20
references: 1108832
references: Arch Gen Psychiatry. 2005 Dec;62(12):1322-30
references: 16330720
references: J Clin Psychiatry. 2006 Aug;67(8):1246-52
references: 16965203
references: Psychopathology. 2005 Sep-Oct;38(5):268-72
references: 16179813
references: Arch Gen Psychiatry. 1998 Jan;55(1):27-32
references: 9435757
references: J Affect Disord. 2006 Dec;96(3):233-7
references: 16427137
references: Psychother Psychosom. 2007;76(1):40-6
references: 17170562
references: J Affect Disord. 2006 Dec;96(3):183-7
references: 16427131
references: Am J Psychiatry. 2006 Feb;163(2):210-6
references: 16449473
references: Am J Psychiatry. 1998 May;155(5):638-45
references: 9585715
references: J Affect Disord. 2006 Dec;96(3):259-69
references: 16997383
references: Am J Psychiatry. 2006 Feb;163(2):232-9
references: 16449476
references: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):68-74
references: 16019119
references: J Affect Disord. 1998 Sep;50(2-3):153-62
references: 9858075
references: J Affect Disord. 1997 Apr;43(2):163-6
references: 9165385
references: Am J Psychiatry. 1992 Dec;149(12):1633-44
references: 1359799
references: J Clin Psychiatry. 2000 Sep;61(9):630-7
references: 11030482
references: J Affect Disord. 2005 Feb;84(2-3):167-78
references: 15708414
references: Arch Gen Psychiatry. 2006 Mar;63(3):246-8
references: 16520428
references: Bipolar Disord. 2006 Oct;8(5 Pt 2):596-617
references: 17042833
references: Acta Psychiatr Scand. 1993 Apr;87(4):279-84
references: 8488750
references: Arch Gen Psychiatry. 1991 Sep;48(9):807-12
references: 1929771
references: Am J Psychiatry. 2005 Nov;162(11):2152-61
references: 16263857
references: Psychiatry Res. 2004 Jul 15;127(3):247-57
references: 15296824
references: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1279-85
references: 15588754
references: J Affect Disord. 2003 Jan;73(1-2):123-31
references: 12507745
references: J Affect Disord. 2003 Jan;73(1-2):133-46
references: 12507746
references: Arch Gen Psychiatry. 2003 Mar;60(3):261-9
references: 12622659
references: Am J Psychiatry. 1982 Jun;139(6):747-52
references: 6805339
references: Lancet. 2007 Mar 17;369(9565):935-45
references: 17368155
references: Bipolar Disord. 2004 Aug;6(4):305-13
references: 15225148
references: J Clin Psychiatry. 2004 Mar;65(3):432-41
references: 15096085
references: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1043-50
references: 16682104
references: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):97-103
references: 16978754
references: J Clin Psychiatry. 2005 Jul;66(7):914-21
references: 16013908
references: Am J Psychiatry. 1988 Feb;145(2):179-84
references: 3341463
references: J Clin Psychiatry. 2003 Apr;64(4):403-7
references: 12716240
references: Psychother Psychosom. 2005;74(1):61-2
references: 15627859
references: J Affect Disord. 2001 Dec;67(1-3):123-32
references: 11869759
references: J Clin Psychiatry. 2000 Nov;61(11):841-50
references: 11105737
references: J Affect Disord. 2003 Jan;73(1-2):49-57
references: 12507737
references: Am J Psychiatry. 2006 Nov;163(11):1905-17
references: 17074942
references: Arch Gen Psychiatry. 2006 Oct;63(10):1130-8
references: 17015815
references: J Affect Disord. 2006 May;92(1):45-54
references: 16488021
references: J Clin Psychiatry. 2005 Jun;66(6):693-704
references: 15960561
references: J Affect Disord. 2003 Jan;73(1-2):87-98
references: 12507741
references: Eur Psychiatry. 2007 Mar;22(2):99-103
references: 17129709
references: Acta Psychiatr Scand. 2004 Dec;110(6):401-7
references: 15521823
references: World J Biol Psychiatry. 2003 Oct;4(4):166-71
references: 14608587
references: J Affect Disord. 2005 Feb;84(2-3):259-66
references: 15708424
references: J Clin Psychiatry. 2006 May;67(5):712-9
references: 16841620
references: Compr Psychiatry. 2004 Nov-Dec;45(6):441-6
references: 15526254
references: Psychopathology. 2007;40(1):54-60
references: 17065838
references: Am J Psychiatry. 2004 Jul;161(7):1264-9
references: 15229060
references: Can J Psychiatry. 2006 Jan;51(1):9-16
references: 16491979
references: J Clin Psychiatry. 1999 Feb;60(2):79-88
references: 10084633
references: Arch Gen Psychiatry. 1982 Oct;39(10):1157-67
references: 7125846
references: J Affect Disord. 2001 Dec;67(1-3):213-9
references: 11869771
references: J Clin Psychiatry. 2006 Jul;67(7):1025-33
references: 16889444
references: J Affect Disord. 2003 Jan;73(1-2):33-8
references: 12507735
references: J Affect Disord. 2006 Aug;94(1-3):111-9
references: 16701902
references: Psychother Psychosom. 2007;76(2):70-6
references: 17230047
references: J Affect Disord. 2005 Oct;88(2):217-33
references: 16125784
references: Arch Gen Psychiatry. 2006 Oct;63(10):1139-48
references: 17015816
references: J Clin Psychiatry. 2006;67 Suppl 11:18-21
references: 17029492
references: J Clin Psychiatry. 2006 Mar;67(3):355-62
references: 16649820
references: J Affect Disord. 2003 Jan;73(1-2):113-22
references: 12507744
references: World J Biol Psychiatry. 2007;8(2):105-11
references: 17455103
references: Arch Gen Psychiatry. 1995 Feb;52(2):114-23
references: 7848047
references: Am J Psychiatry. 1991 Jul;148(7):910-6
references: 2053632
references: J Clin Psychopharmacol. 1998 Dec;18(6):435-40
references: 9864074
references: J Affect Disord. 1997 Oct;46(1):73-7
references: 9387089
references: Int J Neuropsychopharmacol. 2003 Jun;6(2):127-37
references: 12890306
references: Acta Psychiatr Scand. 2003 Jul;108(1):4-14
references: 12807371
references: Am J Psychiatry. 2001 Aug;158(8):1265-70
references: 11481161
references: Compr Psychiatry. 2004 Mar-Apr;45(2):77-82
references: 14999656
references: Compr Psychiatry. 2005 Nov-Dec;46(6):399-404
references: 16275206
references: Can J Psychiatry. 2002 Mar;47(2):125-34
references: 11926074
references: Arch Gen Psychiatry. 2006 Feb;63(2):175-83
references: 16461861
references: Br J Psychiatry. 2006 Aug;189:124-31
references: 16880481
references: Br J Psychiatry. 2006 Oct;189:346-53
references: 17012658
references: Eur Psychiatry. 2006 Jun;21(4):274-9
references: 16675205
references: J Affect Disord. 2005 Feb;84(2-3):149-57
references: 15708412
references: Eur Arch Psychiatry Neurol Sci. 1984;234(1):13-20
references: 6333343
references: Acta Psychiatr Scand. 2004 Nov;110(5):374-82
references: 15458561
references: Am J Psychiatry. 2004 Sep;161(9):1537-47
references: 15337640
references: Psychol Med. 2006 May;36(5):619-27
references: 16438739
references: J Affect Disord. 2005 Feb;84(2-3):225-32
references: 15708420
references: Compr Psychiatry. 2003 Jan-Feb;44(1):21-7
references: 12524632
references: J Affect Disord. 2003 Jan;73(1-2):19-32
references: 12507734
references: Bipolar Disord. 2005 Oct;7(5):441-8
references: 16176437
references: Neuropsychopharmacology. 2003 Jul;28(7):1374-82
references: 12784116
references: Psychiatry Clin Neurosci. 2005 Oct;59(5):570-5
references: 16194260
references: J Clin Psychiatry. 2006 Jan;67(1):48-55
references: 16426088
references: J Clin Psychiatry. 2007 Jan;68(1):102-10
references: 17284137
references: Arch Gen Psychiatry. 1994 Jan;51(1):8-19
references: 8279933
references: Am J Psychiatry. 1970 Jan;126(7):983-7
references: 5409569
references: Am J Psychiatry. 1999 Mar;156(3):426-30
references: 10080559
references: Arch Gen Psychiatry. 2002 Jun;59(6):530-7
references: 12044195
references: Am J Psychiatry. 2005 Jul;162(7):1351-60
references: 15994719
references: Int Clin Psychopharmacol. 1999 Sep;14(5):283-5
references: 10529071
references: J Affect Disord. 2005 Feb;84(2-3):159-66
references: 15708413
references: Br J Psychiatry. 2005 Jul;187:87-8
references: 15994577
references: Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1105-11
references: 12452532
references: Bipolar Disord. 2000 Sep;2(3 Pt 2):281-93
references: 11249806
references: J Affect Disord. 2003 Jan;73(1-2):199-205
references: 12507752
references: Psychol Med. 1988 Feb;18(1):141-53
references: 3363034
references: Arch Gen Psychiatry. 2002 Aug;59(8):736-40
references: 12150650
references: Bipolar Disord. 2003 Dec;5(6):421-33
references: 14636365
references: J Clin Psychopharmacol. 2006 Dec;26(6):600-9
references: 17110817
references: J Affect Disord. 2005 Mar;85(1-2):3-16
references: 15780671
references: J Affect Disord. 2003 Jan;73(1-2):7-18
references: 12507733
references: Am J Psychiatry. 2003 Jan;160(1):4-12
references: 12505793
references: J Clin Psychiatry. 2003 Sep;64(9):1013-24
references: 14628976
references: Arch Gen Psychiatry. 2003 Apr;60(4):392-400
references: 12695317
references: Br J Psychiatry. 2007 Mar;190:189-91
references: 17329735
references: Psychother Psychosom. 2007;76(2):65-9
references: 17230046
references: Psychol Med. 2004 May;34(4):597-611
references: 15099415
references: J Affect Disord. 2002 Apr;68(2-3):203-13
references: 12063148
references: N Engl J Med. 2007 Apr 26;356(17):1711-22
references: 17392295
references: J Affect Disord. 2005 Feb;84(2-3):141-7
references: 15708411
references: Am J Psychiatry. 1995 Mar;152(3):385-90
references: 7864264
references: Compr Psychiatry. 2004 May-Jun;45(3):168-74
references: 15124146
references: Am J Psychiatry. 2006 Feb;163(2):313-5
references: 16449487
references: Am J Psychiatry. 2006 Sep;163(9):1644; author reply 1644-5
references: 16946197
references: Am J Psychiatry. 2003 Jul;160(7):1263-71
references: 12832240
references: J Affect Disord. 2004 Feb;78(2):149-52
references: 14706725
references: J Clin Psychiatry. 2004 May;65(5):627-33
references: 15163248
references: Arch Gen Psychiatry. 2003 Sep;60(9):914-20
references: 12963673
references: J Affect Disord. 2000 Sep;59(3):225-9
references: 10854639
references: J Affect Disord. 2003 Jan;73(1-2):39-47
references: 12507736
references: Aust N Z J Psychiatry. 2005 Aug;39(8):726-9
references: 16050927
references: Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16
references: 16078087
references: Clin Neuropharmacol. 1990;13 Suppl 1:S66-70
references: 2116228
references: Am J Psychiatry. 1978 May;135(5):570-2
references: 347953
references: Acta Psychiatr Scand. 2003 Apr;107(4):268-74
references: 12662249
references: J Affect Disord. 2006 Dec;96(3):189-96
references: 16427136
references: J Affect Disord. 2006 Dec;96(3):197-205
references: 16824616
references: Int Clin Psychopharmacol. 2007 Mar;22(2):93-100
references: 17293709
references: J Affect Disord. 2001 Dec;67(1-3):105-14
references: 11869757
references: Arch Gen Psychiatry. 2005 Oct;62(10):1089-96
references: 16203954
references: Am J Psychiatry. 2000 Nov;157(11):1873-5
references: 11058490
references: Compr Psychiatry. 2005 May-Jun;46(3):159-66
references: 16021584
references: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Sep;27(6):985-91
references: 14499315
references: Am J Psychiatry. 2003 Dec;160(12):2134-40
references: 14638583
references: Bipolar Disord. 2005 Oct;7(5):456-64
references: 16176439
references: Arch Gen Psychiatry. 1984 Nov;41(11):1096-104
references: 6437366
references: Pharmakopsychiatr Neuropsychopharmakol. 1976 May;9(3):100-7
references: 981326
references: J Affect Disord. 2005 Feb;84(2-3):133-9
references: 15708410
references: J Affect Disord. 2005 Apr;85(3):245-58
references: 15780694
references: Psychiatr Clin North Am. 2002 Dec;25(4):699-712, v
references: 12462856